InvestorsObserver
×
News Home

Is Personalis Inc (PSNL) a Stock to Watch This Week?

Friday, January 08, 2021 10:01 AM | InvestorsObserver Analysts

Mentioned in this article

Is Personalis Inc (PSNL) a Stock to Watch This Week?

Overall market sentiment has been high on Personalis Inc (PSNL) stock lately. PSNL receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Personalis Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PSNL!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PSNL Stock Today?

Personalis Inc (PSNL) stock is trading at $38.96 as of 9:58 AM on Friday, Jan 8, a rise of $3.91, or 11.16% from the previous closing price of $35.05. The stock has traded between $35.59 and $39.26 so far today. Volume today is light. So far 100,349 shares have traded compared to average volume of 965,111 shares.

To see the top 5 stocks in the Diagnostics & Research industry click here.

More About Personalis Inc

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services.

Click Here to get the full Stock Score Report on Personalis Inc (PSNL) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App